Sr Scientist/Associate Director, Protein Engineering


We are seeking an individual who is passionate about developing novel therapeutics that harness the immune system in order to eradicate cancer. You will help guide the scientific direction of research and bring novel breakthrough therapeutics from concept to clinical testing. You will advance our pipeline through antibody discovery and engineering in order to produce and identify the best candidates for development.



About Amphivena

Amphivena Therapeutics, Inc. is a cancer immunotherapy company based in South San Francisco, CA developing proprietary first-in-class, T-cell redirecting bispecific antibody-based proteins for the treatment of cancer. The company’s lead drug candidate is AMV564, a CD33/CD3-targeted bispecific that is currently in trials for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

Amphivena’s mission is to eradicate cancers with a breakthrough therapies that harnesses the patient’s own immune system to destroy tumor cells and their precursors. Our aim is to restore the cellular balance needed for proper blood formation, function and circulation, restoring the flow of life to patients.

error: Content is protected !!